• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

万古霉素谷浓度与儿童耐甲氧西林金黄色葡萄球菌菌血症持续时间的关系。

Association Between Vancomycin Trough Concentrations and Duration of Methicillin-Resistant Staphylococcus aureus Bacteremia in Children.

机构信息

Department of Pharmacy, The Johns Hopkins Hospital, Baltimore, Maryland.

Department of Pediatrics, Children's National Health System, Washington, DC.

出版信息

J Pediatric Infect Dis Soc. 2018 Dec 3;7(4):338-341. doi: 10.1093/jpids/pix068.

DOI:10.1093/jpids/pix068
PMID:28992126
Abstract

In a multicenter retrospective study, we sought to determine the optimal vancomycin trough concentration that would impact the duration of methicillin-resistant Staphylococcus aureus bacteremia in children. We found that a median vancomycin trough concentration of <10 µg/mL within the first 72 hours may be associated with a longer duration of bacteremia compared to a median trough concentration of ≥10 µg/mL.

摘要

在一项多中心回顾性研究中,我们试图确定最佳的万古霉素谷浓度,以影响儿童耐甲氧西林金黄色葡萄球菌菌血症的持续时间。我们发现,与万古霉素谷浓度≥10μg/ml 相比,前 72 小时内中位数<10μg/ml 的万古霉素谷浓度可能与更长的菌血症持续时间相关。

相似文献

1
Association Between Vancomycin Trough Concentrations and Duration of Methicillin-Resistant Staphylococcus aureus Bacteremia in Children.万古霉素谷浓度与儿童耐甲氧西林金黄色葡萄球菌菌血症持续时间的关系。
J Pediatric Infect Dis Soc. 2018 Dec 3;7(4):338-341. doi: 10.1093/jpids/pix068.
2
[Persistent bacteremia due to methicillin-resistant Staphylococcus aureus. A result of inadequate treatment].[耐甲氧西林金黄色葡萄球菌所致持续性菌血症。治疗不充分的结果]
Enferm Infecc Microbiol Clin. 2009 Jun;27(6):372-3. doi: 10.1016/j.eimc.2008.12.002. Epub 2009 Mar 31.
3
Impact of initial vancomycin pharmacokinetic/pharmacodynamic parameters on the clinical and microbiological outcomes of methicillin-resistant Staphylococcus aureus bacteremia in children.初始万古霉素药代动力学/药效学参数对儿童耐甲氧西林金黄色葡萄球菌菌血症的临床和微生物学结局的影响。
PLoS One. 2021 Apr 1;16(4):e0247714. doi: 10.1371/journal.pone.0247714. eCollection 2021.
4
Desired vancomycin trough serum concentration for treating invasive methicillin-resistant Staphylococcal infections.治疗侵袭性耐甲氧西林金黄色葡萄球菌感染所需的万古霉素谷浓度。
Pediatr Infect Dis J. 2013 Oct;32(10):1077-9. doi: 10.1097/INF.0b013e318299f75c.
5
The Influence of the Route of Antibiotic Administration, Methicillin Susceptibility, Vancomycin Duration and Serum Trough Concentration on Outcomes of Pediatric Staphylococcus aureus Bacteremic Osteoarticular Infection.抗生素给药途径、甲氧西林敏感性、万古霉素使用时长及血清谷浓度对儿童金黄色葡萄球菌菌血症性骨关节炎感染结局的影响
Pediatr Infect Dis J. 2017 Jun;36(6):572-577. doi: 10.1097/INF.0000000000001503.
6
Impact of source of infection and vancomycin AUC0-24/MICBMD targets on treatment failure in patients with methicillin-resistant Staphylococcus aureus bacteraemia.感染源和万古霉素 AUC0-24/MICBMD 目标对耐甲氧西林金黄色葡萄球菌菌血症患者治疗失败的影响。
Clin Microbiol Infect. 2014 Dec;20(12):O1098-105. doi: 10.1111/1469-0691.12695. Epub 2014 Jul 12.
7
Vancomycin Trough Concentration as a Predictor of Clinical Outcomes in Patients with Staphylococcus aureus Bacteremia: A Meta-analysis of Observational Studies.万古霉素谷浓度作为金黄色葡萄球菌菌血症患者临床结局的预测指标:观察性研究的荟萃分析
Pharmacotherapy. 2015 Oct;35(10):889-98. doi: 10.1002/phar.1638.
8
Best alternative to vancomycin for serious methicillin-resistant Staphylococcus aureus infections: let's just say it.针对严重耐甲氧西林金黄色葡萄球菌感染,万古霉素的最佳替代药物:咱们就直说了吧。
Clin Infect Dis. 2011 Nov;53(9):965-6. doi: 10.1093/cid/cir528. Epub 2011 Aug 31.
9
Evaluation of clinical outcome in children and adolescents receiving vancomycin for invasive infections due to methicillin-resistant Staphylococcus aureus: impact of increasing vancomycin MICs.对因耐甲氧西林金黄色葡萄球菌侵袭性感染而接受万古霉素治疗的儿童和青少年的临床结局评估:万古霉素最低抑菌浓度升高的影响。
Minerva Pediatr. 2018 Jun;70(3):207-211. doi: 10.23736/S0026-4946.16.04688-0. Epub 2016 Dec 22.
10
Area under the concentration-time curve to minimum inhibitory concentration ratio as a predictor of vancomycin treatment outcome in methicillin-resistant Staphylococcus aureus bacteraemia.浓度-时间曲线下面积与最低抑菌浓度比值作为预测耐甲氧西林金黄色葡萄球菌菌血症万古霉素治疗结果的指标。
Int J Antimicrob Agents. 2014 Feb;43(2):179-83. doi: 10.1016/j.ijantimicag.2013.10.017. Epub 2013 Nov 18.

引用本文的文献

1
High vs. low vancomycin therapeutic concentrations in periprosthetic joint infection: A retrospective cohort analysis.人工关节感染中万古霉素高治疗浓度与低治疗浓度的比较:一项回顾性队列分析。
Front Pharmacol. 2025 Mar 27;16:1555276. doi: 10.3389/fphar.2025.1555276. eCollection 2025.
2
Vancomycin Area Under the Curve to Minimum Inhibitory Concentration Ratio for Treatment Effectiveness in Pediatric and Neonatal Staphylococcal Infections: A Systematic Review.万古霉素曲线下面积与最低抑菌浓度比值对儿童及新生儿葡萄球菌感染治疗效果的影响:一项系统评价
J Pediatr Pharmacol Ther. 2025 Feb;30(1):52-64. doi: 10.5863/1551-6776-30.1.52. Epub 2025 Feb 10.
3
Association of Antibiotic Route and Outcomes in Children with Methicillin-Resistant Staphylococcus aureus Bacteremic Osteomyelitis.
耐甲氧西林金黄色葡萄球菌菌血症性骨髓炎患儿抗生素给药途径与治疗结果的相关性
Infect Dis Ther. 2025 Jan;14(1):81-90. doi: 10.1007/s40121-024-01074-2. Epub 2024 Nov 16.
4
Relationship between Vancomycin Trough Serum Concentrations and Clinical Outcomes in Children: a Systematic Review and Meta-Analysis.万古霉素谷浓度与儿童临床结局的关系:系统评价和荟萃分析。
Antimicrob Agents Chemother. 2022 Aug 16;66(8):e0013822. doi: 10.1128/aac.00138-22. Epub 2022 Jul 13.
5
Implementation of a Vancomycin Dose-Optimization Protocol in Neonates: Impact on Vancomycin Exposure, Biological Parameters, and Clinical Outcomes.万古霉素剂量优化方案在新生儿中的实施:对万古霉素暴露、生物学参数和临床结局的影响。
Antimicrob Agents Chemother. 2022 May 17;66(5):e0219121. doi: 10.1128/aac.02191-21. Epub 2022 Apr 25.
6
Management and Prevention of Staphylococcus aureus Infections in Children.儿童金黄色葡萄球菌感染的管理与预防。
Infect Dis Clin North Am. 2022 Mar;36(1):73-100. doi: 10.1016/j.idc.2021.11.006.
7
Population Pharmacokinetics and Dose Optimization of Vancomycin in Critically Ill Children.重症儿童万古霉素群体药代动力学与剂量优化。
Eur J Drug Metab Pharmacokinet. 2021 Jul;46(4):539-546. doi: 10.1007/s13318-021-00695-z. Epub 2021 Jun 22.
8
Impact of initial vancomycin pharmacokinetic/pharmacodynamic parameters on the clinical and microbiological outcomes of methicillin-resistant Staphylococcus aureus bacteremia in children.初始万古霉素药代动力学/药效学参数对儿童耐甲氧西林金黄色葡萄球菌菌血症的临床和微生物学结局的影响。
PLoS One. 2021 Apr 1;16(4):e0247714. doi: 10.1371/journal.pone.0247714. eCollection 2021.
9
Vancomycin Therapeutic Drug Monitoring in Children: New Recommendations, Similar Challenges.儿童万古霉素治疗药物监测:新建议,类似挑战。
J Pediatr Pharmacol Ther. 2020;25(6):472-475. doi: 10.5863/1551-6776-25.6.472.
10
Effect of Vancomycin Loading Doses on the Attainment of Target Trough Concentrations in Hospitalized Children.万古霉素负荷剂量对住院儿童目标谷浓度达标的影响。
J Pediatr Pharmacol Ther. 2020;25(5):423-430. doi: 10.5863/1551-6776-25.5.423.